跳至主要内容
临床试验/NCT01378130
NCT01378130已完成不适用

Central Serous Chorioretinopathy: An Observational Study About Etiology, Course and Prognosis

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Clinical Outcome

研究概览

简要总结

Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.

详细描述

Patients with central serous chorioretinopathy are recruited from the Department of Ophthalmology at the Medical University of Vienna. All patients undergo ETDRS visual acuity measurement, Pelli-Robson contrast examination, Amsler-Grid testing, questionnaire testing, ophthalmologic examination, SD-OCT and polarization-sensitive OCT, fundus autofluorescence, fluorescein angiography, indocyanine-green angiography, fundus photo and microperimetry. Patients are re-examined after an interval of 6 weeks until subretinal fluid is entirely reabsorbed to gain further insides in etiology, course and prognosis of this disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent form
  • Age over 18 years
  • acute episode of Central Serous Chorioretinopathy
  • Symptoms for less than two weeks
  • no treatment on study eye

排除标准

  • bad compliance
  • protected patient group (pregnant women)

结局指标

主要结局

Clinical Outcome

时间窗: 2 years

OCT, Visus

次要结局

  • Subclinical Data(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefan Sacu

Assoc. Prof. Dr.

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验

Central Serous Chorioretinopathy: Etiology, Course... | 临床试验